The question should not be why is the pharmaceutical industry beginning to engage in continuous manufacturing (CM), but rather “what took so long?” Essentially every other industry has been producing materials continuously for decades. Henry Ford began using the assembly line on December 1s ... more
Prof. Dr. Emil W. Ciurczak
Emil W. Ciurczak has advanced degrees in Chemistry from Rutgers and Seton Hall Universities and has been in the pharmaceutical industry since 1970. In 1983, he introduced NIR spectroscopy to pharmaceuticals and consulted for instrument companies. He has published over four dozen articles in refereed journals, over 250 magazine columns, and presented over two hundred technical papers. Since 2005, Emil has been Contributing Editor for Pharmaceutical Manufacturing magazine (for Spectroscopy; 1987-2007 and PharmaEvolution.com 2013-4). He has written and edited several texts and chapters including “Handbook of NIR Analysis” (3 editions), “Pharma and Med Applications of NIR (2 editions),” “Molecular Spectroscopy Workbench,” and chapters on NIR applications in life sciences. Emil sits on several magazine editorial boards, is active in SAS, CNIRS, and was 2002 chair for IDRC and was the 2004 recipient of the EAS Achievements in NIR Award. He has been teaching at a college level since 1979; presenting short courses (NIR, Raman, Design of Experiments, and PAT/QbD) in the US, Europe, South America, and Asia. He holds patents for NIR-based devices and software and consults with various pharmaceutical companies, instrument manufacturers, and the FDA. He was on the PAT Sub-Committee (Validation) for the FDA in 2002 and was a member of the PAT Expert Committee for the USP.